Article Text

Download PDFPDF
CASE REPORT
Rare progression of cholangiocarcinoma: distal femoral metastasis
  1. Sam A MacKenzie1,
  2. Joaquim Stanislas Olivier Goffin1,
  3. Conor Rankin2,
  4. Tom Carter1
  1. 1Department of Trauma and Orthopaedics, Royal Infirmary of Edinburgh, Edinburgh, UK
  2. 2University of Edinburgh College of Medicine and Veterinary Medicine, Edinburgh, UK
  1. Correspondence to Dr Sam A MacKenzie, samuel.mackenzie{at}nhs.net

Summary

Cholangiocarcinoma (CCA) is a rare cancer of the bile duct epithelial cells, with metastases to long bones rarely reported. We present the case of a woman aged 61 years, diagnosed with CCA 6 years previously. She presented with right thigh discomfort, rapidly progressing to immobility with severe pain. Radiological investigations revealed a lytic lesion in her right distal femur, most likely a metastatic deposit, at high risk of pathological fracture. This was managed with an en bloc resection and implantation of a distal femoral replacement. Pathology specimens from theatre confirmed metastatic CCA. Despite sustaining a subsequent fractured neck of femur on the operative side, she recovered well from surgery, with minimal pain and improved mobility on discharge. She restarted palliative chemotherapy. This case illustrates the option of definitive major surgery for the management of metastatic bone disease. As in this case, this can lead to improved symptom control and quality of remaining life.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors SAM and TC were involved in the treatment of the patient and the planning of the case report. JSOG and CR contributed with the literature search and final drafting. All authors read and approved the final version of the manuscript.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.